Molecular Imaging Technologies, LLC (“MIT”) – based in Blue Bell, PA operates positron emission tomography (PET) scanners in markets across the country. The scanners are used in the diagnosis of Alzheimer’s as well as diagnosis and surgery planning for cancer, cardiology, neurology, and psychiatry patients. Navigator provided growth equity to Oncology Molecular Imaging, LLC (“OMI”) in a financing that closed in September 2006. OMI was merged into MIT in 2015.
Learn more about Molecular Imaging Technologies at omillc.com